β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-octadecanoylsphingosine

N-[(2S,3R,4E)-1-{[4-O-(β-D-galactopyranosyl)-β-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]octadecanamide

VOZHMDQUIRUFQW-LOTHNZFDSA-N CHEBI:84759 0 Reactome links 1 studies

1 Observed studies

2 Observed diff profiles

0 Reactome pathways

Metabolite details

Identifier: VOZHMDQUIRUFQW-LOTHNZFDSA-N
InChI Key: VOZHMDQUIRUFQW-LOTHNZFDSA-N
IUPAC name: N-[(2S,3R,4E)-1-{[4-O-(β-D-galactopyranosyl)-β-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]octadecanamide
Preferred name: β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-N-octadecanoylsphingosine
INN name: —
Synonym: LacCer(d18:1/18:0)
ChEBI: CHEBI:84759

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Untargeted metabolomics identifies a plasma sphingolipid-related signature associated with lifestyle intervention in prepubertal children with obesity

Observed in differential profiles